Back to Agenda
Do Flexible Trial Approaches Impede Data Quality? Perception vs Reality
Session Chair(s)
Lindsay Kehoe, MS
Senior Project Manager, Lead Emerging Programs
Clinical Trials Transformation Initiative (CTTI), United States
This panel will discuss whether flexible operational approaches like decentralization, embedding trials in clinical practice, and allowing setting adjustments will affect data quality. Real and perceived impediments to data quality will be explored.
Learning Objective : Identify flexible trial approaches and their benefits and limitations; Assess when flexible trial approaches may impede data quality; Discuss solutions for maintaining data quality.
Speaker(s)
Do Flexible Trial Approaches Impede Data Quality? Perception vs Reality
Cheryl Grandinetti, PHARMD
FDA, United States
Associate Director for Clinical Policy, CDER/OC/OSI/DCCE
Do Flexible Trial Approaches Impede Data Quality? Perception vs Reality
Catherine Gregor, MA, MBA
Florence Healthcare, United States
Chief Clinical Trial Officer
Do Flexible Trial Approaches Impede Data Quality? Perception vs Reality
Kenneth Wiley, PHD
National Center For Advancing Translational Sciences, United States
Section Chief
Have an account?